biote director granted 195,000 stock options

biote Corp. director Marc D. Beer received a grant of stock options covering 195,000 shares of Class A common stock.

Rhea-AI Filing Summary

biote Corp. director Marc D. Beer received a grant of stock options covering 195,000 shares of Class A common stock. The options have an exercise price of $2.20 per share and were awarded at no cost to him.

All 195,000 option shares will vest on the earlier of May 12, 2027 or the day before biote Corp.’s 2027 annual meeting of stockholders, as long as he continues in service through that date. Following this grant, he holds 195,000 stock options directly.

Insider Trade Summary

Grant/Award: 195,000 shares

Grant/Award 1 txn

Insider Beer Marc D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	195,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 195,000 contracts (Direct)

Footnotes (1)

1. F1. All shares subject to the option award shall vest on the earlier of May 12, 2027 or the day prior to the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Key Figures

Options granted: 195,000 options Exercise price: $2.20 per share Options outstanding after grant: 195,000 options +2 more

5 metrics

Options granted 195,000 options Stock Option (Right to Buy) grant on May 12, 2026

Exercise price $2.20 per share Strike price for 195,000 options

Options outstanding after grant 195,000 options Total stock options held following transaction

Vesting date May 12, 2027 Latest vesting date for entire option award

Option expiration May 11, 2036 Expiration date of stock option award

Key Terms

Stock Option (Right to Buy), exercise price, Class A Common Stock, vesting, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

exercise price financial

"conversion_or_exercise_price: "2.2000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Class A Common Stock financial

"underlying_security_title: "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vesting financial

"All shares subject to the option award shall vest on the earlier of May 12, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Annual Meeting of Stockholders financial

"the Issuer's 2027 Annual Meeting of Stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did biote Corp. (BTMD) director Marc D. Beer report on this Form 4?

Marc D. Beer reported receiving a grant of options to purchase 195,000 shares of biote Corp. Class A common stock. These options were granted at no cost and give him the right to buy shares at a fixed $2.20 exercise price in the future.

How many biote Corp. (BTMD) options did Marc D. Beer receive and at what price?

He received stock options covering 195,000 shares of Class A common stock with an exercise price of $2.20 per share. This means he can later buy up to 195,000 shares at $2.20, regardless of the future market price, once vested.

When do Marc D. Beer’s new biote Corp. (BTMD) stock options vest?

All 195,000 option shares vest on the earlier of May 12, 2027 or the day before biote Corp.’s 2027 annual stockholders’ meeting. Vesting requires his continuous service with the company through that vesting date, according to the disclosed footnote.

Is Marc D. Beer’s Form 4 transaction a market purchase or sale of BTMD shares?

The filing shows a grant of stock options, not an open-market purchase or sale. The transaction is coded “A” for grant or award, with zero price paid at grant and a $2.20 exercise price, so it reflects compensation rather than trading activity.

How many biote Corp. (BTMD) options does Marc D. Beer hold after this grant?

After this transaction, he is reported as directly holding 195,000 stock options linked to Class A common stock. This total matches the size of the new grant, and there are no additional derivative positions shown in the provided summary data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 06:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beer Marc D

(Last) (First) (Middle)

C/O BIOTE CORP.

1875 W. WALNUT HILL LN #100

(Street)

IRVING TEXAS 75038

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
biote Corp. [ BTMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.2	05/12/2026		A		195,000		(1)	05/11/2036	Class A Common Stock	195,000	$0.00	195,000	D

Explanation of Responses:

1. All shares subject to the option award shall vest on the earlier of May 12, 2027 or the day prior to the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

	/s/ Kendal McNeely, as Attorney-in-Fact for Marc D. Beer	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)